Projects per year
Personal profile
Education
- 1992 Ph.D., (Pharmacy), Taipei Medical University
- 1985 M.S., (Pharmacy), Taipei Medical University
- 1983 B.S., (Pharmacy), Taipei Medical University
Experience
- 2012 Professor,Department of Pharmaceutical Sciences, Taipei Medical University
- 2003-2012 Professor, Collage of Pharmacy, Taipei Medical University
Research Interests
- Pharmaceutical Analysis
- Development of biomaterials in drug delivery system
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 12 Finished
-
Studies on Development of Thermostable Glycosylated Plga Nanoparticles Loaded with Mrna Encoding Sars-Cov-2 Spike Protein as Covid-19 Vaccine
Ho, H.-O. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Cancer Vaccine Nanoparticles Composed of Mpeg-Plga/Plga-Peg-Plga Mixed Hydrogel for Cancer Immunotherapy by Targeting to Dendritic Cells
Ho, H.-O. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Cancer Vaccine Nanoparticles Composed of Mpeg-Plga/Plga-Peg-Plga Mixed Hydrogel for Cancer Immunotherapy by Targeting to Dendritic Cells
Ho, H.-O. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Cancer Vaccine Nanoparticles Composed of Mpeg-Plga/Plga-Peg-Plga Mixed Hydrogel for Cancer Immunotherapy by Targeting to Dendritic Cells(1/3)
Ho, H.-O. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Development and Optimization for Injectable Thermosensitive Hydrogel-Based Scaffolds with Delivering Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf) in Cancer Immunotherapy
Ho, H.-O. (PI)
8/1/18 → 7/1/19
Project: A - Government Institution › b - National Science and Technology Council
-
Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids
Chou, P. Y., Lai, M. J., Tsai, K. K., Cheng, L. H., Wu, Y. W., Chen, M. C., Pan, S. L., Ho, H. O., Nepali, K. & Liou, J. P., 2024, (Accepted/In press) In: Journal of Medicinal Chemistry. 67, 19, p. 17207-17225 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Composite Hydrogels of Ultrasound-Assisted-Digested Formic Acid-Decellularized Extracellular Matrix and Sacchachitin Nanofibers Incorporated with Platelet-Rich Plasma for Diabetic Wound Treatment
Lin, C. J., Lin, H. L., You, W. C., Ho, H. O., Sheu, M. T., Chen, L. C. & Cheng, W. J., Aug 2023, In: Journal of Functional Biomaterials. 14, 8, 423.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
Liu, Y. H., Chen, L. C., Cheng, W. T., Wei, P. S., Hsieh, C. M., Sheu, M. T., Lin, S. Y., Ho, H. O. & Lin, H. L., Feb 2023, In: Pharmaceutics. 15, 2, 473.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy
Cheng, W. J., Chuang, K. H., Lo, Y. J., Chen, M., Chen, Y. J., Roffler, S. R., Ho, H. O., Lin, S. Y. & Sheu, M. T., Jan 2022, In: Journal of Controlled Release. 344, p. 235-248 14 p.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus) -
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer
Cheng, W. J., Lin, S. Y., Chuang, K. H., Chen, M., Ho, H. O., Chen, L. C., Hsieh, C. M. & Sheu, M. T., 2022, In: International Journal of Nanomedicine. 17, p. 5353-5374 22 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Chen, L.-C. (Contributor), Lin, S.-Y. (Contributor), Sheu, M.-T. (Contributor), Ho, Y.-S. (Contributor), Su, C.-Y. (Contributor), Chen, M. (Contributor), Ho, H.-O. (Contributor) & Chuang, K.-H. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.6213620, https://doi.org/10.6084%2Fm9.figshare.6213620
Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C.-Y. (Contributor), Chen, M. (Contributor), Chen, L.-C. (Contributor), Ho, Y.-S. (Contributor), Ho, H.-O. (Contributor), Lin, S.-Y. (Contributor), Chuang, K.-H. (Contributor) & Sheu, M.-T. (Contributor), Unknown Publisher, May 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
Dataset
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Chang, C.-E. (Contributor), Hsieh, C.-M. (Contributor), Chen, L.-C. (Contributor), Su, C.-Y. (Contributor), Liu, D.-Z. (Contributor), Jhan, H.-J. (Contributor), Ho, H.-O. (Contributor) & Sheu, M.-T. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.5908795.v1, https://tandf.figshare.com/articles/Novel_application_of_pluronic_lecithin_organogels_PLOs_for_local_delivery_of_synergistic_combination_of_docetaxel_and_cisplatin_to_improve_therapeutic_efficacy_against_ovarian_cancer/5908795/1
Dataset
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Hsieh, C.-M. (Contributor), Chen, L.-C. (Contributor), Liu, D.-Z. (Contributor), Ho, H.-O. (Contributor), Su, C.-Y. (Contributor), Sheu, M.-T. (Contributor), Jhan, H.-J. (Contributor) & Chang, C.-E. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.5908795, https://doi.org/10.6084%2Fm9.figshare.5908795
Dataset